Scarica l'app Stockscreener
3.28
2.82%
0.09
Dopo l'orario di chiusura:
3.23
-0.05
-1.52%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.19
Aprire:
$3.18
Volume 24 ore:
702.64K
Relative Volume:
1.00
Capitalizzazione di mercato:
$245.34M
Reddito:
$405.47M
Utile/perdita netta:
$53.66M
Rapporto P/E:
4.5556
EPS:
0.72
Flusso di cassa netto:
$131.28M
1 W Prestazione:
+7.54%
1M Prestazione:
+16.73%
6M Prestazione:
-10.14%
1 anno Prestazione:
-26.29%
Intervallo 1D:
$3.13
$3.31
Intervallo di 1 settimana:
$3.01
$3.82
Portata 52W:
$2.36
$4.92
Orasure Technologies Inc Stock (OSUR) Company Profile
Nome
Orasure Technologies Inc
Settore
Industria
Telefono
(503) 641-6115
Indirizzo
220 E FIRST ST, BETHLEHEM, PA
Confronta OSUR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
3.28 | 226.64M | 405.47M | 53.66M | 131.28M | 0.72 |
|
ISRG
Intuitive Surgical Inc
|
516.16 | 189.29B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
180.90 | 50.30B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
86.96 | 43.02B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
256.42 | 37.53B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
221.59 | 16.25B | 2.90B | 467.20M | 306.90M | 6.37 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-03 | Ripresa | Evercore ISI | In-line |
| 2021-09-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-08-21 | Iniziato | Evercore ISI | Outperform |
| 2020-08-10 | Iniziato | Citigroup | Buy |
| 2020-08-10 | Iniziato | JP Morgan | Neutral |
| 2020-08-07 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-06-25 | Iniziato | Lake Street | Buy |
| 2020-04-21 | Ripresa | Stephens | Equal-Weight |
| 2018-10-23 | Ripresa | Raymond James | Mkt Perform |
| 2018-07-16 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2017-11-02 | Downgrade | Jefferies | Buy → Hold |
| 2017-02-09 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2016-06-13 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-11-05 | Reiterato | Mizuho | Buy |
| 2015-05-07 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-01-23 | Reiterato | Mizuho | Buy |
| 2014-06-12 | Reiterato | Canaccord Genuity | Buy |
| 2014-06-11 | Reiterato | Mizuho | Buy |
| 2012-12-21 | Iniziato | Mizuho | Buy |
| 2012-08-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2012-07-05 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2012-03-27 | Iniziato | JMP Securities | Mkt Outperform |
Mostra tutto
Orasure Technologies Inc Borsa (OSUR) Ultime notizie
OraSure Rebuffs Ron Zwanziger’s Buyout Bid—Will He Try Again? - Smartkarma
Orasure gets takeover bid proposal from Ron Zwanziger- Reuters - MSN
How OraSure Technologies Inc. stock performs during market volatilityProfessional Stock Screener - Newser
CRISPR Diagnostics Market Growth is Powered by Rapid Genetic - openPR.com
OraSure Technologies received takeover bid from industry entrepreneur, sources say - NewsBreak: Local News & Alerts
Ron Zwanziger Proposes Takeover of OraSure TechnologiesNews and Statistics - IndexBox
OraSure Technologies: Riding the Catalyst Wave to Diagnostic Dominance - AInvest
OraSure Technologies Received Takeover Offer From Zwanziger - MarketScreener
Proteomic Blood Collection Devices - Trend Hunter
OraSure's Bold Move: How the Sherlock Acquisition Could Unlock a $1.5B Market and Fuel Explosive Growth - AInvest
OraSure Launches Blood Collection Tube For High-Quality Proteomic Research - Nasdaq
OraSure launches new blood collection device - WFMZ.com
OraSure Technologies Launches HEMAcollect™●PROTEIN for Advancements in Proteomic Research - Quiver Quantitative
OraSure Launches Novel Blood Collection Device for Proteomic Research - GlobeNewswire
Spire Wealth Management Acquires Shares of 16,010 OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Rapid Oral Fluid Screening Device Market | Fast, Non-Invasive - openPR.com
Assenagon Asset Management S.A. Increases Stock Position in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Investor Network: OraSure Technologies, Inc. to Host Earnings Call - ACCESS Newswire
Walgreens and KFF’s Greater Than Campaign to Offer Free HIV/STD Testing in Stores on June 27 - Financial Times
Robust Growth in Medtech Registration System Market - openPR.com
Two Sigma Investments LP Takes $552,000 Position in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Public Employees Retirement System of Ohio Acquires Shares of 76,602 OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Two Sigma Advisers LP Boosts Holdings in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Ameriprise Financial Inc. Has $628,000 Stake in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Purchased by ProShare Advisors LLC - Defense World
Top Penny Stocks To Watch In May 2025 - simplywall.st
OraSure Technologies: Multiple Shots To Deliver Value (NASDAQ:OSUR) - Seeking Alpha
Millennium Management LLC Has $7.79 Million Stake in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Orasure Technologies Inc Files For Mixed Shelf Of Up To $300 MillionSEC Filing - marketscreener.com
OraSure (OSUR) Files for $300 Million Mixed Securities Offering - GuruFocus
Evercore says 23andMe buyout removes downside case for OraSure - Yahoo Finance
OraSure Technologies (NASDAQ:OSUR) Receives “In-Line” Rating from Evercore ISI - Defense World
Jane Street Group LLC Has $1.47 Million Stock Position in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure rises as seen benefitting from 23andMe/Regeneron deal - MSN
OraSure Technologies (OSUR) Rises on Regeneron-23andMe Deal - GuruFocus
OraSure stock rises following Regeneron’s 23andMe acquisition - Investing.com
OraSure Technologies (OSUR) Maintains In-Line Rating with Everco - GuruFocus
Hold Rating on Orasure Technologies Amid 23andMe Acquisition and Revenue Uncertainties - TipRanks
OraSure (OSUR) Sees Positive Outlook with 23andMe Partnership | - GuruFocus
OraSure Technologies (OSUR) Sees Positive Market Reaction | OSUR Stock News - GuruFocus
OraSure (OSUR) Sees Positive Outlook with 23andMe Partnership | OSUR Stock News - GuruFocus
OraSure stock rises following Regeneron’s 23andMe acquisition By Investing.com - Investing.com India
OraSure’s Board of Directors has a new Member Stephen S. Tang, Ph.D., has joined OraSure T - Medical Product Outsourcing
OraSure Technologies (NASDAQ:OSUR) Raised to Hold at StockNews.com - Defense World
Tower Research Capital LLC TRC Grows Position in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Targeted Genomics, OraSure in pact for at-home celiac genetic testing - MSN
10,227 Shares in OraSure Technologies, Inc. (NASDAQ:OSUR) Bought by Raymond James Financial Inc. - Defense World
Voya Investment Management LLC Sells 28,998 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure Technologies Approves Stock Plan Amendment at Annual Meeting - TipRanks
OraSure, Targeted Genomics in pact for at-home celiac genetic testing - Seeking Alpha
OraSure Technologies (OSUR) Partners to Enhance At-Home Celiac T - GuruFocus
Orasure Technologies Inc Azioni (OSUR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.14%
1.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):